Young-Shik Cho, chairman of SD Biosensor, recounts his journey leading diagnostics companies and expanding their offerings through R&D. Cho also compares the challenges of the Chinese market with the potential in the Indian market and offers his opinion on the role of diagnostics in post Covid-19 healthcare.
There is growing interest from capital to invest in diagnostics companies. Within ten years, there is the possibility that this increased support and funding may help to create a new and more innovative business model and platform for diagnostics companies to build and develop from.
